The Anti-CD20 Rituximab Biosimilar Monoclonal Antibody (HDBS0025) is a cutting-edge tool for researchers studying CD20, a cell surface protein involved in immune response regulation. This biosimilar monoclonal antibody, derived from rituximab, has been carefully developed to target and bind specifically to the CD20 protein, allowing for precise detection and analysis in a variety of cell types.CD20 is known for its critical role in B cell function and is a common target for therapies in diseases such as leukemia, lymphoma, and autoimmune disorders. The Anti-CD20 Rituximab Biosimilar Monoclonal Antibody offers researchers a reliable tool for studying the expression and function of CD20, providing valuable insights into the mechanisms underlying these diseases.
With its high specificity and reactivity with human samples, this antibody is ideal for use in various research applications, including Western blot and immunohistochemistry. By enabling detailed investigation of CD20 biology, the Anti-CD20 Rituximab Biosimilar Monoclonal Antibody holds great promise for advancing our understanding of immune-related diseases and developing innovative therapeutic strategies.
Product Name:
Rituximab (Anti-CD20) Biosimilar Antibody
Size:
100 ug
Product SKU:
HDBS0025
Target:
CD20
Host Species:
Chimeric
Reactivity:
Human
Recommended Dilution:
Flow Cyt 1:100
Antibody Type:
Monoclonal
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:
IDEC-C2B8
Description:
Anti-CD20 (rituximab biosimilar) mAb
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:
Powder
Applications
Flow Cyt
Antibody Isotype:
IgG1
Guarantee:
12 months from date of dispatch
Background:
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
